HR 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025, and HR 4348, the Kay Hagan Tick ActSmith bills on stem cell research, Lyme disease pass out of Energy & Commerce’s Health Subcommittee, head to full committee markup
debilitating conditions, and this legislation provides the proper vehicle